US Stock MarketDetailed Quotes

RMTI Rockwell Medical

Watchlist
  • 2.4450
  • +0.0950+4.04%
Trading Nov 19 10:54 ET
79.02MMarket Cap-61125P/E (TTM)

Rockwell Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
19.12%28.32M
42.88%25.83M
15.29%22.68M
14.84%83.61M
14.39%22.09M
27.18%23.77M
-3.22%18.08M
21.98%19.67M
17.57%72.81M
25.97%19.31M
Operating revenue
19.12%28.32M
42.88%25.83M
15.29%22.68M
14.84%83.61M
14.39%22.09M
27.18%23.77M
-3.22%18.08M
21.98%19.67M
17.57%72.81M
25.97%19.31M
Cost of revenue
2.36%22.08M
24.84%21.28M
14.90%19.61M
8.98%74.91M
13.26%19.22M
20.40%21.57M
0.65%17.05M
0.94%17.07M
6.81%68.73M
-3.36%16.97M
Gross profit
183.33%6.24M
340.46%4.55M
17.89%3.06M
113.49%8.7M
22.65%2.87M
183.40%2.2M
-40.80%1.03M
430.66%2.6M
268.47%4.08M
204.89%2.34M
Operating expense
9.24%4.3M
1.08%4.04M
8.99%4.39M
-26.29%15.37M
-20.65%3.42M
-12.17%3.94M
-35.89%3.99M
-31.06%4.03M
-25.29%20.86M
-29.73%4.31M
Selling and administrative expenses
24.91%4.3M
5.49%4.04M
16.60%4.37M
-19.57%14.27M
-21.71%3.25M
-14.22%3.45M
-27.84%3.83M
-12.29%3.75M
-15.86%17.74M
-12.41%4.15M
-Selling and marketing expense
30.58%726K
10.57%586K
19.28%594K
1.48%2.13M
54.13%541K
-27.03%556K
0.76%530K
9.45%498K
-63.47%2.09M
-59.79%351K
-General and administrative expense
23.81%3.58M
4.67%3.45M
16.18%3.78M
-22.39%12.14M
-28.72%2.71M
-11.22%2.89M
-30.99%3.3M
-14.88%3.25M
1.93%15.64M
-1.71%3.8M
Research and development costs
--0
--0
-93.53%18K
-64.51%1.11M
7.69%168K
5.33%494K
-81.97%167K
-82.26%278K
-54.37%3.12M
-88.78%156K
Operating profit
211.46%1.94M
117.40%515K
7.22%-1.32M
60.25%-6.67M
72.18%-547K
53.16%-1.74M
33.98%-2.96M
78.46%-1.43M
44.69%-16.78M
76.48%-1.97M
Net non-operating interest income expense
23.38%-272K
35.55%-223K
-26.01%-407K
-9.83%-2.09M
-169.19%-1.07M
26.35%-355K
28.66%-346K
40.19%-323K
18.61%-1.9M
32.08%-396K
Non-operating interest income
-46.43%30K
-81.63%9K
-62.50%24K
539.39%211K
--42K
--56K
--49K
--64K
50.00%33K
----
Non-operating interest expense
-26.52%302K
-41.27%232K
11.37%431K
18.85%2.3M
158.28%1.11M
-14.73%411K
-18.56%395K
-28.33%387K
-17.97%1.94M
-27.04%429K
Other net income (expense)
51K
7,925.00%321K
101K
220K
4K
0
Gain on sale of security
----
--51K
----
7,925.00%321K
--101K
--220K
----
----
--4K
--0
Income before tax
188.89%1.66M
110.38%343K
1.09%-1.73M
54.82%-8.44M
35.99%-1.51M
55.32%-1.87M
33.46%-3.31M
75.57%-1.75M
42.83%-18.68M
73.58%-2.36M
Income tax
Net income
188.89%1.66M
110.38%343K
1.09%-1.73M
54.82%-8.44M
35.99%-1.51M
55.32%-1.87M
33.46%-3.31M
75.57%-1.75M
42.83%-18.68M
73.58%-2.36M
Net income continuous Operations
188.89%1.66M
110.38%343K
1.09%-1.73M
54.82%-8.44M
35.99%-1.51M
55.32%-1.87M
33.46%-3.31M
75.57%-1.75M
42.83%-18.68M
73.58%-2.36M
Minority interest income
Net income attributable to the parent company
188.89%1.66M
110.38%343K
1.09%-1.73M
54.82%-8.44M
35.99%-1.51M
55.32%-1.87M
33.46%-3.31M
75.57%-1.75M
42.83%-18.68M
73.58%-2.36M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
188.89%1.66M
110.38%343K
1.09%-1.73M
54.82%-8.44M
35.99%-1.51M
55.32%-1.87M
33.46%-3.31M
75.57%-1.75M
42.83%-18.68M
73.58%-2.36M
Basic earnings per share
171.43%0.05
105.56%0.01
40.00%-0.06
71.76%-0.37
75.00%-0.05
69.57%-0.07
58.14%-0.18
88.10%-0.1
65.80%-1.31
80.77%-0.2
Diluted earnings per share
157.14%0.04
105.56%0.01
40.00%-0.06
71.76%-0.37
75.00%-0.05
69.57%-0.07
58.14%-0.18
88.10%-0.1
65.80%-1.31
80.77%-0.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 19.12%28.32M42.88%25.83M15.29%22.68M14.84%83.61M14.39%22.09M27.18%23.77M-3.22%18.08M21.98%19.67M17.57%72.81M25.97%19.31M
Operating revenue 19.12%28.32M42.88%25.83M15.29%22.68M14.84%83.61M14.39%22.09M27.18%23.77M-3.22%18.08M21.98%19.67M17.57%72.81M25.97%19.31M
Cost of revenue 2.36%22.08M24.84%21.28M14.90%19.61M8.98%74.91M13.26%19.22M20.40%21.57M0.65%17.05M0.94%17.07M6.81%68.73M-3.36%16.97M
Gross profit 183.33%6.24M340.46%4.55M17.89%3.06M113.49%8.7M22.65%2.87M183.40%2.2M-40.80%1.03M430.66%2.6M268.47%4.08M204.89%2.34M
Operating expense 9.24%4.3M1.08%4.04M8.99%4.39M-26.29%15.37M-20.65%3.42M-12.17%3.94M-35.89%3.99M-31.06%4.03M-25.29%20.86M-29.73%4.31M
Selling and administrative expenses 24.91%4.3M5.49%4.04M16.60%4.37M-19.57%14.27M-21.71%3.25M-14.22%3.45M-27.84%3.83M-12.29%3.75M-15.86%17.74M-12.41%4.15M
-Selling and marketing expense 30.58%726K10.57%586K19.28%594K1.48%2.13M54.13%541K-27.03%556K0.76%530K9.45%498K-63.47%2.09M-59.79%351K
-General and administrative expense 23.81%3.58M4.67%3.45M16.18%3.78M-22.39%12.14M-28.72%2.71M-11.22%2.89M-30.99%3.3M-14.88%3.25M1.93%15.64M-1.71%3.8M
Research and development costs --0--0-93.53%18K-64.51%1.11M7.69%168K5.33%494K-81.97%167K-82.26%278K-54.37%3.12M-88.78%156K
Operating profit 211.46%1.94M117.40%515K7.22%-1.32M60.25%-6.67M72.18%-547K53.16%-1.74M33.98%-2.96M78.46%-1.43M44.69%-16.78M76.48%-1.97M
Net non-operating interest income expense 23.38%-272K35.55%-223K-26.01%-407K-9.83%-2.09M-169.19%-1.07M26.35%-355K28.66%-346K40.19%-323K18.61%-1.9M32.08%-396K
Non-operating interest income -46.43%30K-81.63%9K-62.50%24K539.39%211K--42K--56K--49K--64K50.00%33K----
Non-operating interest expense -26.52%302K-41.27%232K11.37%431K18.85%2.3M158.28%1.11M-14.73%411K-18.56%395K-28.33%387K-17.97%1.94M-27.04%429K
Other net income (expense) 51K7,925.00%321K101K220K4K0
Gain on sale of security ------51K----7,925.00%321K--101K--220K----------4K--0
Income before tax 188.89%1.66M110.38%343K1.09%-1.73M54.82%-8.44M35.99%-1.51M55.32%-1.87M33.46%-3.31M75.57%-1.75M42.83%-18.68M73.58%-2.36M
Income tax
Net income 188.89%1.66M110.38%343K1.09%-1.73M54.82%-8.44M35.99%-1.51M55.32%-1.87M33.46%-3.31M75.57%-1.75M42.83%-18.68M73.58%-2.36M
Net income continuous Operations 188.89%1.66M110.38%343K1.09%-1.73M54.82%-8.44M35.99%-1.51M55.32%-1.87M33.46%-3.31M75.57%-1.75M42.83%-18.68M73.58%-2.36M
Minority interest income
Net income attributable to the parent company 188.89%1.66M110.38%343K1.09%-1.73M54.82%-8.44M35.99%-1.51M55.32%-1.87M33.46%-3.31M75.57%-1.75M42.83%-18.68M73.58%-2.36M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 188.89%1.66M110.38%343K1.09%-1.73M54.82%-8.44M35.99%-1.51M55.32%-1.87M33.46%-3.31M75.57%-1.75M42.83%-18.68M73.58%-2.36M
Basic earnings per share 171.43%0.05105.56%0.0140.00%-0.0671.76%-0.3775.00%-0.0569.57%-0.0758.14%-0.1888.10%-0.165.80%-1.3180.77%-0.2
Diluted earnings per share 157.14%0.04105.56%0.0140.00%-0.0671.76%-0.3775.00%-0.0569.57%-0.0758.14%-0.1888.10%-0.165.80%-1.3180.77%-0.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data